Shanghai Tianyong Engineering Co., Ltd. (603895.SH) won the bid for the annual capacity of 540,000 units for the whole line transformation project of the Jin Tan H4J15 assembly line.
Tianyong Intelligent (603895.SH) announced that the company recently received a notice from Jiangsu Jiafeng Engineering Consulting Co., Ltd. (referred to as "...
Shanghai Tianyong Engineering (603895.SH) announced that the company recently received a bid notification from Jiangsu Jiafeng Engineering Consulting Co., Ltd. (referred to as the "bidding agency") regarding the bid of Jiangsu Zhongzhiyang Investment Management Co., Ltd. (referred to as the "bidding party") for the 2024 Jintan H4J15 assembly line capacity of 540,000 units per year. The total project involves the whole line renovation (Phase 1, Phase 2). Shanghai Tianyong Engineering Equipment Co., Ltd. has been selected as the winning bidder for the "2024 Jintan H4J15 assembly line capacity of 540,000 units per year whole line renovation project (Phase 1, Phase 2)" with a bid amount of 31 million yuan for Phase 1 and 21 million yuan for Phase 2.
Related Articles

HK Stock Market Move | HENLIUS (02696) is currently up nearly 9%. The company's three innovative solid tumor drugs have been accepted for IND at the same time.

Expand Gaode's global model and establish a physical business department to launch related product applications.

HK Stock Market Move | Gambling stocks generally weaken, GALAXY ENT (00027) dropped nearly 3%, Macau's gambling revenue in December last year fell short of expectations.
HK Stock Market Move | HENLIUS (02696) is currently up nearly 9%. The company's three innovative solid tumor drugs have been accepted for IND at the same time.

Expand Gaode's global model and establish a physical business department to launch related product applications.

HK Stock Market Move | Gambling stocks generally weaken, GALAXY ENT (00027) dropped nearly 3%, Macau's gambling revenue in December last year fell short of expectations.

RECOMMEND

Hong Kong Listed Companies’ Return To A Shares Heats Up As New “H To Shenzhen A” Case Emerges
05/01/2026

What Do The Top Ten Biopharma IPOs Of 2025 Tell Us?
05/01/2026

Asia’s Stock Markets Deliver A Strong 2025: Korea Soars 76%, Japan Tops Bubble‑Era Peak, Indonesia Records Best Year In 11 Years
05/01/2026


